SEIKO-INSTRUMENTS-INC.
Seiko Instruments Inc. (SII) announced the release of the S-19200 Series automotive LDO regulator with high input voltage of 50V, adopting a newly developed compact package TO-252-5S (6.5 x 6.5 x t1.3 mm) with high heat dissipation.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151101005004/en/
The new TO-252-5S can be mounted on the existing pad area of the industry standard TO-252-5 (DPAK) and has approximately the same heat dissipation, while realizing a mounting area reduction of 35% and height reduction of nearly 50%. An even more compact HSOP-6 package (6.0 x 5.02 x t1.75 mm) capable of high heat dissipation is also available. This IC is suitable for automotive ECUs and typical applications include power supply for automotive interior electrical applications (car body, headlights, ITS, accessories, car navigation systems, car audio systems, etc.)
The S-19200 Series was specifically developed to meet the demanding high quality requirements for automotive use. The 50V maximum input voltage (rating 60V) and the operating temperature range up to 125 degrees C enable operations in high input voltage and high temperature applications. Moreover, the current consumption is an extremely low 4.0 μA typ. during operation, and the excellent load response characteristics allow this IC to be used in applications with large load fluctuations.
The output voltage is selectable from 2.0V to 15.0V in 0.1V steps and the input voltage range is 3.0V to 50V. The output accuracy is ±1.0% (Tj=+25 degree C) and a ceramic capacitor of 0.1 μF or more can be used for input and output capacitors. Additional features include overcurrent protection circuit, thermal shutdown circuit, and ON/OFF circuit. The package is Lead-free (Sn 100%) and halogen-free. The S-19200 Series is AEC-Q100 qualified (contact SII sales offices for details) and the PPAP approval is also available. SII offers a thermal simulation service for the S-19200 Series which suggests thermal resistance values and recommended wiring ratio to help select appropriate package options.
Detailed information:
S-19200A/BxxH (105 degree C operation)
http://datasheet.sii-ic.com/en/automotive_voltage_regulator/S19200A_BxxH_E.pdf
S-19200A/BxxA
(125 degree C operation)
http://datasheet.sii-ic.com/en/automotive_voltage_regulator/S19200A_BxxA_E.pdf
Please visit:
http://www.sii-ic.com/en/
About Seiko Instruments Inc. (SII)
http://www.sii.co.jp/en/
View source version on businesswire.com: http://www.businesswire.com/news/home/20151101005004/en/
Contact:
Seiko Instruments Inc.
Yasuko Arai, +81-43-211-1111 (Japanese
inquiry only)
Corporate Communications Dept.
pr@sii.co.jp
Online
Inquiry: https://krs.bz/sii/m/sii_inquiry_en
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release
- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc
Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology6.6.2025 16:00:00 CEST | Press release
IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine.With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty.This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 14:00:00 CEST | Press release
Pivotal Study Advances to Establish Histotripsy as a Non-Thermal, Surgery-Free Alternative to Destroy and Liquefy Kidney Tumors HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison
Norwegian Tech Firm Builds Military Command Center in 24 Hours6.6.2025 13:45:00 CEST | Press release
Norwegian technology provider Cyviz has successfully developed a fully mobile and ballistic-proof command center - designed, configured, and made operational in just 24 hours. The solution was showcased during a military exercise led by the Dutch Ministry of Defence and has already sparked interest from NATO members and civil protection agencies across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606640770/en/ Cyviz demonstrates rapid deployment capability with a mobile, container-based control room for defense and crisis response Cyviz and its partners constructed the command room inside a 14-ton container designed for transport on standard military vehicles and resistant to machine gun fire. The unit was deployed at a military base in the Netherlands, where Cyviz was tasked with delivering a fully functional command-and-control environment, under strict time constraints and in a high-stakes simulation. "You do
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom